Authors
Latest:
Julie Harper, MD, to Present a Rosacea Research Roundup and PearlsShe shares her top 5 considerations for all dermatology drug prescribers.
Latest:
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin HealthJeanine Downie, MD, FAAD, discussed critical updates on tattoo ink safety, new dermatologic technologies, biostimulators, and more at AAD 2025.
Latest:
Habits, Cultural Norms, and Rapid Advances In Technology Have Dramatically Changed the Aesthetic Medicine LandscapeAmy B. Lewis, MD, explores the evolution of aesthetic dermatology, delving into injection sophistication, devices, and top procedures.
Latest:
AI Model Shows Promise in Reducing Skin Cancer Detection BiasA novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair.
Latest:
Jordan Miller, MD: 2024 Dermatology PredictionsAdvancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.
Latest:
Efficacy and Safety of Laser Treatment for Patients With AcneA panelist discusses how laser treatments demonstrate a strong safety profile and proven efficacy for patients with acne, with clinical studies showing significant reduction in both inflammatory and noninflammatory lesions.
Latest:
Key Insights From the SPD Pre-AAD Meeting: Advances, Challenges, and the Future of Pediatric DermatologyMercedes E. Gonzalez, MD, reflects on the SPD meeting as well as challenges and advances in pediatric dermatology.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Redefining Vitiligo Management: FDA-Approved Topical Ruxolitinib and the Evolving Treatment ParadigmPearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and its impact on management strategies.
Latest:
Study Reveals Potential Genetic Connection Between Hidradenitis Suppurativa and Increased Risk of CAD and DiabetesOlder adults with higher genetic risk for HS show increased risks for coronary artery disease and diabetes, according to UK Biobank data.
Latest:
Jill Waibel, MD, FAAD: Innovations in Laser Modalities for the Treatment of ScarsWaibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.
Latest:
The Burden of AD Flares and Impact of Ruxolitinib Initiation on Utilization of Other TherapiesPosters at AMCP Nexus analyzed the burden of flares on patients with atopic dermatitis (AD) and the impact initiating ruxolitinib cream had on use of other therapies.
Latest:
85% of Survey Respondents Do Not Know What Actinic Keratosis IsThe survey conducted by Almirall included participants in the US and Europe.
Latest:
Pulsed Dye Lasers for Cosmetic ProceduresPulsed dye lasers are now being used for several different dermatologic conditions.
Latest:
Diamant Thaçi, MD, PhD: Understanding the Impact of Nemolizumab Efficacy Post Approvals in EU, UK, and SwitzerlandProfessor Diamant Thaçi, MD, PhD, discusses findings from the ARCADIA and OLYMPIA clinical trial programs, highlighting nemolizumab’s rapid efficacy in treating atopic dermatitis and prurigo nodularis.
Latest:
New Tech for SkinThere are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Latest:
Rare Immune Cell May Predict Immunotherapy Response in MelanomaVd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
Latest:
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging TherapiesReview emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
Comparing Devices to Assess Facial Pigmentary and Inflammatory ConditionsPrecision measurements are necessary to improve the current therapeutic armamentarium in pigmentary disorders.
Latest:
Navigating Pregnancy, Dermatology, and Drug SafetyKatherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
Latest:
Challenges and Successes in Photodynamic TherapyBrad Glick, DO, MPH, discusses common challenges clinicians may encounter with photodynamic therapy (PDT) and offers resolution strategies, while also sharing insights on the skin conditions and patient populations where PDT has proven to be a successful treatment option.
Latest:
Clinical Experience and Diagnosis of GPPPanelists discuss how clinical experience in diagnosing generalized pustular psoriasis (GPP) requires recognizing its hallmark features of widespread sterile pustules on inflamed skin, distinguishing it from other pustular conditions, and understanding the genetic mutations and triggers that can precipitate this rare but potentially life-threatening form of psoriasis.
Latest:
Lauren Miller, PA-C, Highlights the Value of Collaboration With APPs and MoreMiller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.
Latest:
Case 2: Male, 20 Years OldAn expert in the management of skin conditions provides an overview of a 20-year-old male diagnosed with atopic dermatitis, discussing key insights from a round table discussion. The conversation focused on effective management strategies, best practices for prior authorization approvals, and the significance of treatment vehicles.
